◆英語タイトル:Owens & Minor Inc (OMI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9969
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and surgical products related to admission, anesthesia, diagnostics and equipment, maternity and nursery, O.R. products, patient care, respiratory, and urology. It also offers distribution services and supply-chain management services to healthcare providers and suppliers of medical and surgical products. The company offers its products and services to independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare products’ manufacturers, and the federal government. It has operations in North America and Europe. Owens & Minor is headquartered in Richmond, Virginia, the US.
Owens & Minor Inc (OMI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Owens & Minor Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Owens & Minor Inc, Medical Devices Deals, 2012 to YTD 2018 9
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Owens & Minor Completes Public Offering of 3.875% Notes Due 2021 for USD275 Million 11
Owens & Minor Completes Public Offering of 4.375% Notes Due 2024 for USD275 Million 13
Acquisition 15
Owens & Minor to Acquire Byram Healthcare 15
Owens & Minor Completes Acquisition Of Movianto From Celesio For US$158 Million 17
Owens & Minor Inc – Key Competitors 18
Owens & Minor Inc – Key Employees 19
Owens & Minor Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 24
Financial Announcements 24
Aug 07, 2018: Owens & Minor reports financial results for 2nd quarter 2018 24
Feb 14, 2018: Owens & Minor Reports 4th Quarter & Full-Year 2017 Financial Results 26
Jan 31, 2018: Owens & Minor Previews 2017 Preliminary Financial Results 28
Nov 01, 2017: Owens & Minor Reports 3rd Quarter 2017 Financial Results 29
Aug 01, 2017: Owens & Minor Reports 2nd Quarter 2017 Financial Results 31
May 02, 2017: Owens & Minor Reports 1st Quarter 2017 Financial Results 33
Mar 16, 2017: Owens & Minor Outlined its New Strategic Plan and Reaffirmed its Financial Outlook for 2017 and 2018 at Annual Investor Meeting 34
Feb 14, 2017: Owens & Minor Reports 4th Quarter & Full-Year 2016 Financial Results 35
Corporate Communications 37
Jun 22, 2018: Owens & Minor Names Timothy P. Connolly as EVP, Operations & Supply Chain-Global Solutions 37
Jun 04, 2018: Owens & Minor Appoints Interim Chief Financial Officer, as well as a Chief Accounting Officer 38
Mar 27, 2018: Owens & Minor Appoints Shana Neal as SVP & Chief Human Resources Officer 39
Feb 28, 2018: Owens & Minor Names Dominion Energy Executive, Mark McGettrick, to its Board of Directors 40
Mar 13, 2017: Owens & Minor Welcomes New EVP of Global Manufacturer Services 41
Feb 10, 2017: Owens & Minor Announces That Healthcare Executive Barbara B. Hill Has Been Elected to Its Board of Directors 42
Feb 10, 2017: Craig R. Smith, Chairman of the Owens & Minor Board of Directors, Announces His Retirement 43
Government and Public Interest 44
Feb 27, 2018: Fusion5 Announces Formation to Meet Provider Needs in Value-Based Healthcare Models Including CMS’ BPCI Advanced Initiative 44
Other Significant Developments 45
Oct 23, 2017: Healthier Communities 20/20: A Clear Vision for Our Future; Owens & Minor will Explore this Theme at its 12th Annual Healthcare Supplier Diversity Symposium 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Tables
Owens & Minor Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Owens & Minor Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Owens & Minor Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Owens & Minor Inc, Medical Devices Deals, 2012 to YTD 2018 9
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Owens & Minor Completes Public Offering of 3.875% Notes Due 2021 for USD275 Million 11
Owens & Minor Completes Public Offering of 4.375% Notes Due 2024 for USD275 Million 13
Owens & Minor to Acquire Byram Healthcare 15
Owens & Minor Completes Acquisition Of Movianto From Celesio For US$158 Million 17
Owens & Minor Inc, Key Competitors 18
Owens & Minor Inc, Key Employees 19
Owens & Minor Inc, Other Locations 21
Owens & Minor Inc, Subsidiaries 22
List of Figures
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Owens & Minor Inc, Medical Devices Deals, 2012 to YTD 2018 9